MINI FUTURE SHORT - DIASORIN Share Price

Certificat

P15PH4

NLBNPIT15PH4

Market Closed - Borsa Italiana 10:00:04 01/03/2022 pm IST
83.4 ^EUR	+0.30%

Current month	+0.30%
1 month	+3.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

DiaSorin receives clearance from US FDA for NxTAG panel	17/05	AN
DiaSorin S p A : receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2	16/05	PU
Funds move on DiaSorin and Leonardo on the Mib.	16/05	AN
Futures bullish; traders believe in Fed cut	16/05	AN

More news

Static data

Product type	Knock-Out mit Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P15PH4
ISIN	NLBNPIT15PH4
Date issued	05/11/2021
Strike	216.9 €
Maturity	18/12/2025 (580 Days)
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	99.7 €
Lowest since issue	28.51 €

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company